1. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis
- Author
-
Antonio Riva, Elizabeth H. Gray, Sarah Azarian, Ane Zamalloa, Mark J.W. McPhail, Royce P. Vincent, Roger Williams, Shilpa Chokshi, Vishal C. Patel, and Lindsey A. Edwards
- Subjects
Chronic liver disease ,Gut inflammation ,Intestinal barrier function ,Bacterial translocation ,Cytokines ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background & Aims: Gut dysbiosis and inflammation perpetuate loss of gut barrier integrity (GBI) and pathological bacterial translocation (BT) in cirrhosis, contributing to infection risk. Little is known about gut inflammation in cirrhosis and how this differs in acute decompensation (AD). We developed a novel approach to characterise intestinal immunopathology by quantifying faecal cytokines (FCs) and GBI markers. Methods: Faeces and plasma were obtained from patients with stable cirrhosis (SC; n = 16), AD (n = 47), and healthy controls (HCs; n = 31). A panel of 15 cytokines and GBI markers, including intestinal fatty-acid-binding protein-2 (FABP2), d-lactate, and faecal calprotectin (FCAL), were quantified by electrochemiluminescence/ELISA. Correlations between analytes and clinical metadata with univariate and multivariate analyses were performed. Results: Faecal (F) IL-1β, interferon gamma, tumour necrosis factor alpha, IL-21, IL-17A/F, and IL-22 were significantly elevated in AD vs. SC (q
- Published
- 2020
- Full Text
- View/download PDF